HEALTH AND SAFETY

» Drug, Devices, and Supplements

» Physician Accountability

» Consumer Product Safety

» Worker Safety

» Health Care Delivery

» Auto and Truck Safety

» Global Access to Medicines

» Infant Formula Marketing

 

Health Letter Archive


How to order a print version of Health Letter

You may order back issues, which are available for $3.00 each. If you have questions about Health Letter, please call (202) 588-1000 and ask to speak with a representative from the Health Research Group.

Ordering by credit card

Call Member Services at (202) 588-1000 to order by credit card. Public Citizen accepts Visa, MasterCard, American Express and Discover. Unfortunately, it is not currently possible to order the Health Letter online.

Ordering by check

Mail a check payable to Public Citizen to:

Health Letter
1600 20th Street NW
Washington, DC 20009

Health Letter Cumulative Alphabetical Subject index

View a comprehensive list of subjects covered in Health Letter from its first issue in 1985 through the present.

Copyright © Health Letter.
All rights reserved.
Material appearing in Health Letter may not be reprinted without permission from the editor.

Health Letter

Health Letter 2000 through 2009


Jump to year:
2009 - 2008 - 2007 - 2006 - 2005 - 2004 - 2003 - 2002 - 2001 - 2000

2009

December 2009; Vol. 25, No. 12

  • What Happened in Health Care in 2009
  • The Price We Pay for Uninsurance
  • Analysis of USPSTF 2009 Revised Breast Cancer Screening Recommendations
  • Product Recalls
  • Outrage: The Case of Neurontin: Skewed Research in the Service of Selling

November 2009; Vol. 25, No. 11

  • Health Reform: Where Will the Money Come From?
  • Product Recalls
  • Harvard Study Finds Nearly 45,000 Excess Deaths Annually Linked to Lack of Health Coverage
  • Outrage: AHIP’s Actuarial Acrobatics

October 2009; Vol. 25, No. 10

  • The Uninsured in the United States: What the Rise to 46.3 Million Means
  • Public Citizen Proposes Basic Patient Safety Reforms that Would Save 85,000 Lives and $35 Billion a Year
  • A Review of Homeopathy
  • Product Recalls
  • Health Debate or Health Charade?
  • Outrage: Drug Company Inducements to Doctors: Not Par for the Course

September 2009; Vol. 25, No. 9

  • Obama Administration Must Make Disciplinary Records of Nurses, Health Workers Available to Hospitals, Nursing Homes
  • Letter Urging Secretary Sebelius to Provide Hospitals and Nursing Homes Access to Names of Disciplined Nurses and Other Health Workers
  • A Call to Action: Why We Need Medical Resident Work Hour Reform
  • Product Recalls
  • Are We Now Twice as Sad? The Drug Industry and Doctors Think We Are!
  • Outrage: Ghostly Prescriptions

August 2009; Vol. 25, No. 8

  • Dr. Sidney Wolfe’s Testimony before Subcommittee on Health at Hearing on Health Insurance
  • Dr. Steffie Woolhandler’s Testimony before Health Subcommittee at Hearing on Health Insurance
  • Letter to the Editor of the Washington Post Regarding the Coverage of the Recent Congressional Hearing on Single-Payer
  • Ineffectual Medical Treatments Misleadingly Produce “Good” Results
  • Product Recalls
  • Outrage: Medical Publisher Offers Bribes for Writing Favorable Book Reviews

July 2009; Vol. 25, No. 7

  • Q & A on the Current Health Debate: What Does a ‘Public Plan Option’ Mean and Why Does Public Citizen Oppose it?
  • Hospitals Drop the Ball on Physician Oversight
  • A Dictionary of Health Policy Terms, Part III
  • Product Recalls
  • Outrage: Language Matters: Poor Communication Can Mean Poor Health Care

June 2009; Vol. 25, No. 6

  • Vermont’s Pharmaceutical Laws Move Toward Fuller Disclosure
  • What is Comparative Effectiveness Research, and Why is it Being Badmouthed?
  • Intro to Comparative Health Systems
  • Product Recalls
  • Outrage: A Coalition of the Scared

May 2009; Vol. 25, No. 5

  • Public Citizen’s Health Research Group Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2006-2008
  • Product Recalls
  • Outrage: Psychoprostitution

April 2009; Vol. 25, No. 4

  • Stretching the TARP to Cover Health Care
  • Bereavement: A Look at the Grieving Process and How to Cope with Loss
  • Product Recalls
  • How Much Is A Year of Your Life Worth?
  • WARNING: MRI Scans May Burn Patients Wearing Transdermal Drug Patches
  • Outrage: High Deductibles for Limited Eligibles

March 2009; Vol. 25, No. 3

  • Massachusetts’ Plan: A Failed Model for Health Care Reform
  • Product Recalls
  • Having Health Insurance Does Not Mean Having Health Care
  • Public Hospitals, Community Clinics Suffering Under Massachusetts Health Care Reform
  • Outrage: Ending the Insanity of Failed State Health Insurance Reforms

February 2009; Vol. 25, No. 2

  • Our Perfectly Designed U.S. Healthcare System
  • Public Citizen Endorses Single Payer National Health System, Joins Leadership Conference for Guaranteed Health Care
  • U.S. Inmates Suffer from Chronic Illness and Poor Access to Health Care
  • Informed Consent and Shared Decision-Making
  • Product Recalls
  • Outrage: “Morning After” Contraception Too Difficult to Get

January 2009; Vol. 25, No. 1

  • Single Payer Health Care in Taiwan: Borrowing Ideas, Improving on Medicare
  • Health Letter Volume Index, 2008
  • Indulgence and Innovation in Medical Care
  • Product Recalls
  • Smokeless Tobacco: Rebranding Nicotine, Repackaging Death
  • Outrage: Full Body Scams: Not Your Source for Peace of Mind

2008

December 2008; Vol. 24, No. 12

  • In Case You Missed It: What Happened in Health in 2008
  • Calculating Your Risk of Death from Disease and Accidents
  • Product Recalls
  • Outrage: Is the Uterus a Pre-Existing Condition?

November 2008; Vol. 24, No. 11

  • The Uninsured in the United States: What the Drop to 45.7 Million Means
  • Pharma Should Not Foot the Bill for Your Doctor’s Continuing Medical Education
  • Weighing Conscience Protection Against a Patient’s Right to Information
  • Product Recalls
  • Outrage: Mongering Diseases to Hawk Pills: The Case of Fibromyalgia

October 2008; Vol. 24, No. 10

  • A Tale of Three Cities: Racial and Ethnic Disparities in Premature Mortality in the District of Columbia, 2005
  • Product Recalls
  • Outrage: Big Tobacco Targets College Students

September 2008; Vol. 24, No. 9

  • Long-Term Care Insurance: Perennial Questions, Updated Answers
  • Product Recalls
  • Outrage: Athletic Prowess and the Doping of Consumers

August 2008; Vol. 24, No. 8

  • Unseen Payoffs and the Poverty of Prevention
  • Just How Does the U.S. Health Care System Stack Up?
  • Product Recalls
  • "Mistakes Were Made": Disclosing Medical Errors
  • Outrage: Botox, Mark Spitz, Nadia Comenici and Willie Nelson

July 2008; Vol. 24, No. 7

  • What Are Presidential Candidates (And Their Advisors) Talking About? Part II
  • Macular Degeneration
  • Product Recalls
  • Outrage: Why is Darvon (Darvocet/propoxyphene) Still Around, Hurting People?

June 2008; Vol. 24, No. 6

  • Drug Research: To Test or to Tout?
  • Backsliding on Childhood Immunizations
  • Public Citizen Urges Removal of Ortho-Evra Patch from Market
  • Product Recalls
  • Study Finds New Blood Substitutes Increase Risk of Death, Heart Attacks; Authors Question FDA’s Approval Process, Records Access
  • Outrage: Human Experimentation and Speedy For-Profit Ethical Review Board

May 2008; Vol. 24, No. 5

  • Health Policy Placebos
  • Physician Support for National Health Insurance on the Rise
  • Public Citizen’s Health Research Group Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2005-2007
  • Product Recalls
  • Outrage: "Physician, Heal Thyself" Not Always Simple

April 2008; Vol. 24, No. 4

  • Medical Errors and State Reporting of Adverse Events
  • Public Citizen Testifies on Drug Safety Before Congress
  • Product Recalls
  • Outrage: Unnecessary Medical Radiation: Children the Most Vulnerable

March 2008; Vol. 24, No. 3

  • Medical Records: Q&A
  • Public Citizen Launches Now Blog
  • Market-Based Failure: A Second Opinion on U.S. Health Care Costs
  • Product Recalls
  • Outrage: Scarce Kidneys: Why U.S. Transplantation Policies Are Inherently Inequitable and How They Can Be Changed

February 2008; Vol. 24, No. 2

  • Lost in Translation: Why the Highly-Touted Dutch Health System Would Not Be a Good Idea for the U.S.
  • Product Recalls
  • Outrage: Drug Industry Spends Almost Twice As Much on Promotion of Drugs As on Research

January 2008; Vol. 24, No. 1

  • Boundaries Without Barriers: Cross-Border Health in the European Union
  • Product Recalls
  • Health Letter Volume Index 2007 and Cumulative Index
  • Outrage: Pay for Performance: Incentives Gone Awry

2007

December 2007; Vol. 23, No. 12

View as PDF
  • What Happened in U.S. Health Care in 2007?
  • Update on Avandia
  • Product Recalls
  • MedWatch
  • Outrage: Illegal Kickbacks From Artificial Knee and Hip Manufacturers to Orthopedic Surgeons

November 2007; Vol. 23, No. 11

  • Rethinking Health Care for the Elderly
  • More Than A Prayer for Single Payer
  • Product Recalls
  • Another U.S. Go-It-Alone Policy
  • Outrage: "Reminder Ads": Innuendo Minus Information

October 2007; Vol. 23, No. 10

View as PDF
  • Equal Pay for Equal Work? Not For Medicaid Doctors
  • Hoodia: Another Weight Loss Scam
  • Product Recalls
  • Research as Public Relations
  • Outrage: Are Hospitals Making Us Sicker?

September 2007; Vol. 23, No. 9

View as PDF
  • Improving Public Access to Clinical Trial Information
  • Scapegoating Immigrants
  • Product Recalls
  • The Latest Data on the Uninsured
  • Outrage: Manipulating the Hispanic Market: The Case of Viagra

August 2007; Vol. 23, No. 8

  • What Are The Presidential Candidates Talking About?: A Brief Dictionary of Health Policy Terms
  • Product Recalls
  • Now, Let the Victim Beware
  • Taming Technology
  • Outrage: Our Health Care System

July 2007; Vol. 23, No. 7

View as PDF
  • Q&A on the Human Papilloma Virus Vaccine Gardasil
  • Product Recalls
  • Organ Donations: What Price, The Priceless?
  • Taming the Giant Corporation
  • Outrage: PDUFA: Buying Votes, Selling Unsafe Products

June 2007; Vol. 23, No. 6

View as PDF
  • Public Citizen’s Ranking of State Medical Boards’ Serious Disciplinary Actions, 2004-2006
  • Product Recalls
  • Outrage: Avandia: Not-So-New News of Heart Problems With the Popular Diabetes Drug

May 2007; Vol. 23, No. 5

View as PDF
  • Back to Basics: Clean Water as a Medical Milestone
  • Doctors and Drug Company Favors
  • Drugs for Weight Loss
  • Product Recalls
  • Do Not Use Dextromethorphan
  • Outrage: What’s Wrong With This Story?: Pharmaceutical Company Files Sales Director for Telling the Truth

April 2007; Vol. 23, No. 4

View as PDF
  • Unsettling Scores: A Ranking of State Medicaid Programs
  • Product Recalls
  • Outrage: Walling Off Medicaid Beneficiaries

March 2007; Vol. 23, No. 3

View as PDF
  • Public Citizen Petitions FDA to Ban Third-Generation Oral Contraceptives
  • Product Recalls
  • Cough and Cold Meds Send Babies to Hospital
  • American Life Expectancy on Rise
  • Colds: How to Treat Them
  • Outrage: And The Oscar for Best Drugumentary Goes To…

February 2007; Vol. 23, No. 2

View as PDF
  • Medicaid @ 40: Why It Matters
  • Work and Wellness: Collusion or Collision?
  • A Statement by Dr. Sidney Wolfe, Health Letter’s Editor-in-Chief
  • Conflicts of Interest: An Issue That Will Not Go Away
  • Product Recalls
  • Conflicts of Interest Among Clinical Investigators
  • Outrage: Essay: What’s Making Us Sick Is an Epidemic of Diagnoses

January 2007; Vol. 23, No. 1

View as PDF
  • Dr. Wolfe’s Diet Revolution
  • Product Recalls
  • Health Letter Volume Index 2006 and Cumulative Index
  • Outrage: Conflicts of Interest: The Hidden Side of Science

2006

December 2006; Vol. 22, No. 12

  • Report of Doctor Disciplinary Information on State Web Sites: A Survey and Ranking of State Medical and Osteopathic Board Web Sites in 2006
  • Product Recalls
  • Outrage: What If We Were Equal?

November 2006; Vol. 22, No. 11

  • New York City’s Answer to the Diabetes Epidemic: Screen, Trace, Track and Act: More Public Health, Fewer Pharmaceuticals
  • A Broader Context: Diabetes in the United States and in the World
  • What is Diabetes?
  • Bogus Cures for Diabetes on the Internet
  • The New York City Department of Health’s Recommendations for Living with Diabetes
  • Product Recalls
  • Diabetes in the U.S.: The Epidemic in Numbers
  • Outrage: Placing the Promise of Prevention in Context: The Case against the Diabetes Drug Rosiglatizone (Avandia)

October 2006; Vol. 22, No. 10

  • Crime and Punishment, Medical Style
  • The US FDA at a Crossroads
  • No “Alternative”
  • Product Recalls
  • Outrage: The Number of Uninsured in the United States Reaches 46.6 Million

September 2006; Vol. 22, No. 9

  • The Changing Dynamics of C-Sections in the United States: Cesarean Delivery on Maternal Request: Part II
  • Patients Without Borders: The Emergence of Medical Tourism: Part II
  • The “Ultimate Prize” for Big Tobacco: Opening the Chinese Cigarette Market by Cigarette Smuggling
  • Product Recalls
  • Outrage: Fairness Creams in South Asia: A Case of Disease Mongering?

August 2006; Vol. 22, No. 8

  • Health Care Reform in the United States: Arguments for a Single Payer System
  • The Changing Dynamics of C-Sections in the United States: Part I
  • Product Recalls
  • Outrage: Pharmaceutical Marketing and the Invention of the Medical Consumer

July 2006; Vol. 22, No. 7

  • Patients Without Borders: The Emergence of Medical Tourism
  • Study Finds Many Favor A Single Payer System
  • Product Recalls
  • Much-Needed Corrective Lenses for the “Clinical Eye”
  • Laser Therapy for Smoking: Shining a Laser on Bad Advertising Practices
  • Outrage: The Growing Gap in Reproductive Health

June 2006; Vol. 22, No. 6

  • Public Citizen’s Health Research Group Ranking of State Medical Board Disciplinary Actions: 2003-2005
  • Poll: People Understand Systemic Problems at FDA
  • Product Recalls
  • Exercise Status and Future Dementia
  • Study Finds Glucosamine, Chondroitin Ineffective for Joint Pain
  • Outrage: Pharmaceuticals Need Price Controls

May 2006; Vol. 22, No. 5

  • The Fight Against Disease Mongering
  • From Unease to Disease
  • Blurring the Boundaries between Health and Illness
  • Product Recalls
  • Outrage: Massachusetts’ Mistake

April 2006; Vol. 22, No. 4

  • Hearing Aids: Why Medicare Should Provide Coverage
  • Despite New Study, Crestor Should Not Be Prescribed
  • Product Recalls
  • Chromium Industry Withheld Data from OSHA
  • Outrage: Darvon and Darvocet: What Are They Thinking?

March 2006; Vol. 22, No. 3

  • Drugs Used to Treat High Blood Pressure
  • Elevated Cholesterol Levels
  • Who Needs Nondietary Potassium Supplementation?
  • Product Recalls
  • Outrage: Health Care Quality?

February 2006; Vol. 22, No. 2

  • High Blood Pressure
  • The Unaffordably High Cost of Cancer Drugs
  • Product Recalls
  • Exercise in People Age 65 Years and Older Is Associated with Lower Risk for Dementia
  • Outrage: Why Over-the-Counter? Diet Drug Poses Risks, Questionable Benefits

January 2006; Vol. 22, No. 1

  • Saving Money When Buying Prescription Drugs: Part III: Caution When Purchasing Drugs on the Internet
  • Recall Update
  • Product Recalls
  • Health Letter Volume Index 2004 and Cumulative Index
  • Outrage: Medicare Part D: What Benefit?

2005

December 2005; Vol. 21, No. 12

  • Drivel from the Drug Industry/U.S. Government Axis
  • Saving Money When Buying Prescription Drugs, Part II: Generic Drugs
  • Product Recalls
  • Outrage: Second Chances: Big Tobacco Enters the Health Care Industry

November 2005; Vol. 21, No. 11

  • Curbing the Influence of the Drug Industry: A British View
  • Product Recalls
  • Saving Money When Buying Prescription Drugs
  • Public Citizen Writes of Drug Company Deception in Lancet Medical Journal
  • FDA Reverses Course of Needle Sticks, Shows Profound Indifference to Worker Health
  • Outrage: Helping Drug Reps Serve You Better: National Healthcare Census

October 2005; Vol. 21, No. 10

  • FDA Device Regulation Leaves Unsafe Products on Market: Public Citizen Petitions for Better Rules
  • Product Recalls
  • Antibiotic Clarithromycin (BIAXIN) Can Have Deadly Interaction with Anti-Gout Drug Colchicine
  • Three Misleading Direct-to-Consumer Ad Campaigns
  • Insurers Have it Wrong on Malpractice—Again
  • Industry Drug Guidelines Will Do Little to Prevent Misleading Ads

September 2005; Vol. 21, No. 9

  • New “Diseases”: Often Invented by Drug Industry Marketing Departments to Sell You Drugs
  • Ten Additional Causes of Medical Malpractice Lawsuits
  • Product Recalls
  • Preventing the Epidemic of Skin Cancer: A Guide for Protecting Yourself and Your Family
  • Asthma Medicines That Can Cause Asthma Attacks: Do Not Use Serevent, Advair, or Foradil
  • Outrage: FDA Denial of Public Citizen’s Petition to Ban Meridia is Misguided

August 2005; Vol. 21, No. 8

  • Sleight-of-Hand: Merck Contemplated Vioxx Reformulation in 2000 While Denying Risk
  • Can I Buy You Dinner? Pharmaceutical Companies Increasingly Use Doctors’ Talks as Sales Pitches
  • Product Recalls
  • Pennsylvania Data Show Large Number of Hospital-Acquired Infections
  • Decreased Child Mortality a Possibility with Appropriate Funding, Study Shows
  • FDA Issues Guidelines for Consumer Prescription Drug Information
  • FDA Approves Depression Device Without Proof of Effectiveness
  • Outrage: Warning: Contains FDA-Approved Drug…

July 2005; Vol. 21, No. 7

  • Medical Journals are an Extension of the Marketing Arm of Pharmaceutical Companies
  • Scientific Misconduct: Rare or Rampant?
  • Successfully Pushing Paxil on Television
  • Product Recalls
  • Outrage: Drug Rep (Salesman) vs. Dr. Grobstein

June 2005; Vol. 21, No. 6

  • Ranking the State Medical Boards’ Serious Disciplinary Actions: 2002-2004
  • Product Recalls
  • Outrage: Repeat Malpractice Offenders Compromise Patient Safety

May 2005; Vol. 21, No. 5

  • In Memoriam: Bill Hines, 1917-2005
  • “…Makes You Stop and Think”
  • Product Recalls
  • HMO-Medicare Crisis: Is Health Insurance for the Elderly on the Way Out?
  • Outrage: The Causes of Misprescribing and Overprescribing

April 2005; Vol. 21, No. 4

  • George A. Silver, M.D., 1913-2005: In Memoriam
  • Misprescribing and Overprescribing of Drugs
  • Product Recalls
  • Outrage: The Problem Is…

March 2005; Vol. 21, No. 3

  • Medical Liability Reform? FDA Does Not Adequately Protect Consumers
  • Illness and Medical Bills Cause Half of All Bankruptcies
  • Product Recalls
  • Outrage: Get the Lead Out!

February 2005; Vol. 21, No. 2

  • Nine Reasons Why Older Adults are More Likely than Younger Adults to Have Adverse Drug Reactions
  • Bereavement
  • Product Recalls
  • Outrage: Take Drugs Off the Market

January 2005; Vol. 21, No. 1

  • Health Care: Beyond Markets
  • Product Recalls
  • Health Letter Volume Index 2004 and Cumulative Index
  • Outrage: HHS Fails to Warn About Preventing Falls in Older Adults

2004

December 2004; Vol. 20, No. 12

  • Single Payer: Good for Business
  • Product Recalls
  • The View From Vermont

November 2004; Vol. 20, No. 11

  • America’s Neglected Veterans: 1.7 Million Who Served Have No Health Coverage
  • Blockbuster Arthritis Drug Rofecoxib (VIOXX) Withdrawn from Market: Worst Pills, Best Pills News Readers Warned in 2001: DO NOT USE
  • Product Recalls
  • Screening for Colon Cancer: Insurance Coverage Still Spotty
  • Outrage: “Stealth PACs” Give Drug Industry Big Bang for its Bucks

October 2004; Vol. 20, No. 10

  • Cheap Trick: Bush’s Health-Savings Accounts are a Bargain—Provided You Never Get Injured or Sick
  • You Have Reached the Medicare Program. Please Hold for the Next Available Source of Inaccurate Information
  • Product Recalls
  • Discovering Health Care Fraud and “Telling”: Whistleblowers

September 2004; Vol. 20, No. 9

  • Blood Safety
  • Product Recalls
  • Why is the U.S. So Far Behind on Prescription Drug Price Controls?
  • DO NOT USE! Lawsuit Reveals Serious Safety Problems with The Nonsteroidal Anti-Inflammatory Drug (NSAID) Valdecoxib (BEXTRA)
  • Even Moderate Amounts of Exercise Can Prevent Weight Gain
  • DO NOT USE! Long-Term Treatment with the Alzheimer’s Disease Drug Donepezil (ARICEPT) Ineffective
  • Weapons of Mass Destruction and Medicine

August 2004; Vol. 20, No. 8

  • The People Have Spoken: The Drug Industry Doesn’t Serve Us Well
  • Boutique Medicine (Concierge Care) Revisited
  • Product Recalls
  • Doctor Bribing in Italy
  • Suicide Risk Added To the Professional Product Labeling for Eight Antidepressants
  • DO NOT USE—Save Your Money: Dextromethorphan (DELSYM or generic) or Diphenhydramine (BENADRYL or generic) Ineffective for Nighttime Cough in Children
  • Outrage: Medizine: Drug Ads Masquerading as News

July 2004; Vol. 20, No. 7

  • The High Costs of For-Profit Care
  • It Takes Two to Tango (or to Bribe): Big-Time Crime in the Pharmaceutical Industry with the Help of Doctors
  • Product Recalls
  • Regular Exercise May Prolong Your Life
  • The Wild, Wild Web for Prescription Drugs
  • Outrage: Breast Implants as High School Graduation Presents: Just Poor Parenting or Child Abuse?

June 2004; Vol. 20, No. 6

  • Patent Fiction
  • National Health Insurance: Falling Expectations and the Safety Net
  • Product Recalls
  • DO NOT USE! Dangerous Drug for Irritable Bowel Syndrome: Constipation Predominant Tegaserod (ZELNORM)
  • Improper Antibiotic Treatment for Bladder Infections
  • Outrage: Serious and Growing Problem of Antibiotic Resistance

May 2004; Vol. 20, No. 5

  • Public Citizen’s Health Research Group Ranking of State Medical board Serious Disciplinary Actions in 2003
  • Product Recalls
  • The Antidepressant Fluoxetine (PROZAC) and Suicidal Ideation—Déjà vu 1991
  • Saline Spray: Do Try This at Home
  • Outrage: FDA Frustrates the Intent of Congress for 17 Years

April 2004; Vol. 20, No. 4

  • Prescriptions and Profit
  • Publicity about Recent Studies on the Cholesterol-Lowering Statin Drugs: Misinterpretations
  • Product Recalls
  • Direct-to-Consumer Advertising: Bad News for Most Patients and Doctors
  • Comments of a Canadian Doctor: After 10 years, Has Anything Really Changed for the Better?
  • Outrage: Serious Concerns about a Portable Ventilator (respirator)

March 2004; Vol. 20, No. 3

  • Overselling Donepezil (ARICEPT) and Exploiting Patients with Alzheimers Disease: Why Isn’t The FDA Stopping These Ads?
  • Product Recalls
  • New Jersey Slow to Police Problem Physicians
  • Protecting Yourself from Mad Cow Disease Infection
  • Outrage: Kidney Dialysis Facilities: Serious Problems of Compliance with Medicare Quality Standards

February 2004; Vol. 20, No. 2

  • Study Shows National Health Insurance Could Save $286 Billion on Health Care Paperwork
  • Product Recalls
  • Canada Outdoes U.S. on Flu Vaccine Policy
  • Harlot: How to Achieve positive Results without actually Lying to Overcome the Truth
  • AARP Rebellion Grows
  • Outrage: AARP and Medicare Legislation

January 2004; Vol. 20, No. 1

  • Breast Cancer: New Information About Screening Mammography and Genetics
  • Product Recalls
  • Health Letter Volume Index 2003 and Cumulative Index
  • Outrage: National Institute of Mental health Fails to Fund Important Mental Health Research

2003

December 2003; Vol. 19, No. 12

  • Documentary Shows Problems in Pharmaceutical Industry, FDA
  • Product Recalls
  • FDA Issues Public Health Advisory On Antidepressants and Suicide Risk in Children
  • How to Report Adverse Reactions to the FDA
  • Outrage: Do Not Use: Dangerous Antidepressant Nefazodone (SERZONE) Withdrawn From the Market in Canada

November 2003; Vol. 19, No. 11

  • A Conversation With Sheldon Krimsky: Uncoupling Campus and Company
  • Advertising Dietary Supplements on the Internet: Supplementing Income Rather than Health
  • Product Recalls
  • Do Not Use: Asthma Drug Montelukast (SINGULAIR) for the Treatment of Hay Fever
  • Outrage: We Have Met the Enemy and He is Us

October 2003; Vol. 19, No. 10

  • A New Health Care Gimmick: Concierge Medicine
  • Do Not Use: Rosuvastatin (CRESTOR) — A New But More Dangerous Cholesterol-Lowering “Statin” Drug
  • A Reminder About the Dangerous of Aspirin and Reye’s Syndrome
  • Product Recalls
  • DO NOT USE! Strong New Safety Warning Added For The Asthma Inhaler Salmeterol (SEREVENT)
  • Meridia — Weight Loss or Health Loss?
  • Outrage: Food and Drug Disaster

September 2003; Vol. 19, No. 9

  • Sweetening the Pill
  • CPSC Says Consumers Continue to Use Dangerous Products Despite Recalls, Warnings
  • Product Recalls
  • Outrage: FDA-Approved Patient Information Needed

August 2003; Vol. 19, No. 8

  • Profitably Inventing New Diseases
  • Secret No More: Medicare investigation results now fair game
  • Bad Medicine: Why Bush's malpractice policy will only help insurers
  • Product Recalls: From sunscreen to extension cords: watch out!
  • Do Not Use Finasteride (PROSCAR, PROPECIA) For Preventing Prostate Cancer
  • Outrage: Taxol: How the NIH gave away the store

July 2003; Vol. 19, No. 7

  • Bush Administration Plan to Privatize Medicare Would Limit Seniors' Choice of Doctors
  • The Big Fix: A Book Review: How the pharmaceutical industry rips off American consumers
  • Product Recalls
  • New Warning! Risk of stroke when the antipsychotic risperidone (RISPERDAL) is prescribed for dementia
  • Outrage of the Month: How Bayer shipped HIV-containing blood products to Asia and Latin America

June 2003; Vol. 19, No. 6

  • Doctor, Advocate, Activist
  • Health Research Group Ranks Medical Boards
  • Product Recalls
  • Resisting Antibiotic-Resistant Bacteria
  • Outrage: Democracy by Disclosure: A Book Review

May 2003; Vol. 19, No 5

  • Ephedra: Scientific Evidence Versus Money/Politics
  • Calcium By Any Other Name is Still Calcium
  • Bereavement
  • Product Recalls
  • Outrage: The Uncovering of an Undercoder: A Story of Medicine Triumphant

April 2003; Vol. 19, No. 4

  • Cost, Quality and Choice: Winning Less Expensive, Better Quality Health Care For America
  • Affordable Reform That Benefits Patients
  • The Dangers of Some Screening Tests
  • A Free Ride for Bad Doctors
  • Product Recalls
  • Outrage: Nexium Offers Unique Advantage Over Generic Omeprazole

March 2003; Vol. 19, No. 3

  • Worst Pills, Best Pills News Now Available Online!
  • Selling "New" Drugs Using Smoke and Mirror (Images)
  • Foggy Thinking as Inhaled Flu Vaccine Nears FDA Approval
  • Product Recalls
  • MedWatch Reporting Form
  • Outrage: U.S. Air Force Flies High on Dexedrine

February 2003; Vol. 19, No. 2

  • Medical Errors, Not Lawsuits, are Real Cause of Rising Malpractice Insurance Premiums
  • Inadequate Doctor Discipline by State Medical Boards
  • Government Publishes Adult Immunization Schedule
  • Product Recalls
  • Tamoxifen for Breast Cancer Prevention?
  • Outrage: Wanna Quit Smoking? Who you Gonna Call? Philip Morris?

January 2003; Vol. 19, No. 1

  • "Neglected to Death:" The Scandalous Condition of American Nursing Homes
  • Product Recalls
  • Phyllis McCarthy Annual Public Interest Award
  • Health Letter Volume Index, 2002 and Cumulative Index
  • Outrage: Remedies Needed to Address the Pathology in Reporting Adverse Reactions and Food and Drug Administration Use of Reports

2002

December 2002; Vol. 18, No. 12

  • 25,00 U.S. Deaths a Year Because of For-Profit Kidney Dialysis
  • Low Quality HMOs Hide Performance Data from Public, Says Journal of the American Medical Association Study
  • Blind to the Data: OSHA Looks the Other Way as Workers Exposed to Hexavalent Chromium
  • Product Recalls
  • Drug Safety Withdrawals: Who is Responsible for Notifying Patients?
  • "Dangerous Political Cowardice:" FDA Fails to Ban Dietary Supplement Ephedra
  • Outrage: The Corruptible Academic-Industry Partnership

November 2002; Vol. 18, No. 11

  • Unsafe Drugs: Congressional Silence is Deadly (Part 2)
  • FDA Caves In to Industry, Fails to Adequately Address Tylenol Overdoses
  • Product Recalls
  • High Blood Pressure in the Physician’s Office?
  • Alzheimer’s Disease: Major Market Here to Stay
  • Outrage: GAO Report Backs Link Between Drug User Fees and Higher Rate of Drug Withdrawals

October 2002; Vol. 18, No. 10

  • ADAPT Trial for Alzheimer’s Disease Prevention Should Be Canceled
  • Will a Vitamin a Day Keep the Doctor Away?
  • Questionable Doctors Online
  • Product Recalls
  • Outrage: Strange Bedfellows: How the Tobacco and Drug Industries Collaborated to Undermine Anti-Smoking Efforts

September 2002; Vol. 18, No. 9

  • The Invisible Plague: The Rise of Mental Illness from 1750 to the Present
  • Update on the Illegal Promotion of Gabapentin (Neurontin)
  • Product Recalls
  • Pressure On to Ban Ephedra
  • West Nile Virus Activity
  • Outrage: Health Research Group Asks for Metabolife President to be Investigated

August 2002; Vol. 18, No. 8

  • Ethical Implications of Cosmetic Surgery for Aging
  • Product Recalls
  • Is Your Doctor Selling You to the Highest Bidder?
  • Hormone Replacement Therapy
  • Outrage: "It’s Botox Night at Hopkins"

July 2002; Vol. 18, No. 7

  • Big Pharma Buys Psychiatry: An Aura of Scandal
  • Product Recalls
  • Conflict of Interest? Medical Journal Changes Policy of Finding Independent Doctors to Write
  • Nicotine Lollipops: Sweet, Addictive and Illegal
  • Cancer.gov
  • Ten Years Ago Today: The Suppressed Democratic Study Group's "Stealth" Survey Surfaces
  • Outrage: Department of Health and Human Services Fails to Ban Ephedra or Issue Adequate Warnings

June 2002; Vol. 18, No. 6

  • Questionable Doctors Online: Disciplined Doctor Resource Debuts on Public Citizen Web Site in June
  • Understanding Risks — and the Risks You Run by Misunderstanding Them
  • Overworked Doctors Walk Off the Job
  • Product Recalls
  • Preventing Heat Induced Death and Illness
  • Outrage: New Study: Wait Seven Years to Use New Drugs

May 2002; Vol. 18, No. 5

  • Public Citizen’s Health Research Group Ranking of State Medical Board Disciplinary Actions in 2001
  • Survey of Doctor Disciplinary Information on State Web Sites
  • Product Recalls
  • Outrage: Possible Corruption at the American Heart Association

April 2002; Vol. 18, No. 4

  • Saving Your Sight — Early Detection is Critical
  • Nursing Homes: More Can Be Done to Protect Residents from Abuse
  • Product Recalls
  • Outrage: No Care for the Care Givers

March 2002; Vol. 18, No. 3

  • Direct-To-Consumer Advertising — Education or Emotion Promotion?
  • Analysis: HMOs Try New Approach to Keep Drug Cost Down
  • Rx Needed for Medical Journals
  • Product Recalls
  • Outrage: We Wish this Hospital Well

February 2002; Vol. 18, No. 2

  • The Destruction of Medicine by Market Forces: Teaching Acquiescence or Resistance and Change?
  • Good Business Suggestions [Business Week on controlling drug costs]
  • Product Recalls
  • Health Research Group Asks New Mexico to Sanction Doctor
  • New Study Shows Low Income Minority Seniors Restrict Use of Prescription Drugs
  • What Ails the Mass. Board of Medicine?
  • FDA Action on Red Cross Long Overdue
  • Canadians Begin Recall of Dangerous Drug Supplement Ephedra
  • Outrage: The AMA Does It Again

January 2002; Vol. 18, No. 1

  • What’s New In Screening Mammography
  • Product Recalls
  • Clearing the Smoke from Low-Tar and Nicotine Cigarettes
  • Health Letter Volume Index 2001 and Cumulative Index
  • Outrage: Oops — Did It Again (or, Escondido in Escondido)

2001

December 2001; Vol. 17, No. 12

  • "You Can’t Leap a Chasm in Two Jumps"
  • Product Recalls
  • "...Makes You Stop and Think!"
  • Philip Morris Brags About its Killer Cigarettes
  • Living and Dying
  • DEA Promotes Public Citizen Information
  • Outrage: "I Have Never Seen Anything Like This"

November 2001; Vol. 17, No. 11

  • Insufficient Credits
  • Drugs for Possible Exposure to Anthrax: What Makes Sense?
  • An Epidemic of Lung Disease Caused by a Quarter-Century of Government Inaction
  • Product Recalls
  • Colds: How to Treat Them
  • Outrage: The Lupron Loophole — and the Doctors Who Exploited It

October 2001; Vol. 17, No. 10

  • Health Care Reform Coming? Don’t Bet the Farm On It
  • Unsafe Drugs: Congressional Silence Is Deadly (Part 1)
  • Product Recalls
  • Outrage: Do Not Use Ephedra

September 2001; Vol. 17, No. 9

  • Criminal Charges Should Be Filed Against Schering-Plough
  • Direct-to-Consumer (DTC) Ads: Illegal, Unethical or Both
  • Below the Beltway
  • Product Recalls
  • Outrage: Crouching Government, Hidden Snake Oil

August 2001; Vol. 17, No. 8

  • In Memory of Our Colleague Henry Bergman
  • Questionable Hospitals
  • Product Recalls
  • Outrage: Darvon, Darvocet, Darvon Compound

July 2001; Vol. 17, No. 7

  • Hormone Therapy: Doubts Grow
  • Drug Companies’ Antics Can Really Make You Sick
  • Product Recalls
  • Why Doesn’t the Government Know About These Doctors?
  • Outrage: "Operation Cure.All" Wages New Battle in Ongoing War Against Internet Fraud

June 2001; Vol. 17, No. 6

  • Public Citizen Petitions OSHA to Limit Residents’ Working Hours
  • Preventing Heat-Induced Death and Illness
  • Product Recalls
  • Outrage: Lontronex and the FDA: A Fatal Erosion of Integrity

May 2001; Vol. 17, No. 5

  • Public Citizen’s Health Research Group Ranking of State Medical Board Disciplinary Actions in 2000
  • How to Reduce the Risk of Mad Cow Disease in the United States
  • Product Recalls
  • Outrage: Dietary Supplements: The FDA Should Do More

April 2001; Vol. 17, No. 4

  • Latin America: the Answer to Drug Companies' Problems?
  • Election 2000 Commentators
  • Product Recalls
  • One Drug Company -- Shering-Plough -- Faces Massive Recalls
  • High Drug Prices for Research or Profit?
  • Is This Doc Deadly? His Practice Hasn't Been Perfect
  • Outrage: CASHCOW -- Here a Moo, There a Moo

March 2001; Vol. 17, No. 3

  • Is the U.S. Safe from Mad Cow Disease? Could We Be Safer?
  • Still Hard to Swallow
  • Product Recalls
  • It's the Calories that Count
  • COX-2 Inhibitors Vioxx and Celebrex: Keep Staying Away
  • Consumer Product Safety Commission Finally Sees the Light on Lead in Candles
  • Outrage: A Discussion of Misleading Drug Ads

February 2001; Vol. 17, No. 2

  • Unhealthy Partnership: How Massachusetts and Its Managed Care Contractor Shortchange Troubled Children
  • Bad Policy, Worse Medicine
  • Let the ‘Non-Governments' Beware: Multinational Organizations Are Out to Co-opt You and Your Tactics
  • Product Recalls
  • Outrage: None of Your Business

January 2001; Vol. 17, No. 1

  • FDA Fails to Get the Point on Safe Needles for Health Care Workers
  • Sex Education Information on the Internet: Caveat Emptor!
  • Product Recalls
  • Volume Index, 2000 and Cumulative Alphabetic Index
  • Outrage: FDA Accuses Red Cross of Jeopardizing the Safety of the Blood Supply

2000

December 2000; Vol. 16, No. 12

  • Is U.S. Health Really the Best in the World?
  • Osteoporosis
  • A Better Quality Alternative: Single Payer National Health Reform
  • Medical Fluoroscopy: Radiation-induced Skin Injury
  • Product Recalls
  • Outrage: America's Ailing Medical Education System

November 2000; Vol. 16, No. 11

  • Review of Calcium Supplements; Ads Exaggerate Differences
  • Long-Acting Calcium Channel Blockers Inferior to Older Blood Pressure Lowering Drugs in Preventing Heart Attacks and Heart Failure
  • When is a Patient Group Not a Patient Group?
  • Product Recalls
  • Television and Obese Children: A Strong Connection
  • Sitting Backwards is Safer
  • HRG Petitions the FDA to Ban Dangerous Diet and Cough/Cold Drugs in Over-the Counter Products
  • Outrage: "Too Much Corporate Power"

October 2000; Vol. 16, No. 10

  • Epilepsy
  • How To Report Adverse Reactions to the Food and Drug Administration
  • Product Recalls
  • Outrage: Victimizing the Vulnerable

September 2000; Vol. 16, No. 9

  • 20,125 Questionable Doctors
  • Product Recalls
  • Outrage: Human Experimentation for Profit

August 2000; Vol. 16, No. 8

  • The Pharmaceutical Industry--To Whom is It Accountable?
  • Hundreds of Thousands of Workers at Risk from Hexavalent Chromium, Study Obtained Through FOIA Shows
  • Product Recalls
  • Report Estimates Air Lead Levels from Some Candle Wicks at Up to 36 Times EPA Standards
  • The Risks of Tranquility
  • Outrage: Erroneous and Misleading Reports in Media About Prescription Drugs

July 2000; Vol. 16, No. 7

  • Patients' Rights Bills
  • Bereavement
  • Product Recalls
  • Outrage: Inspector General's Study on Human Experimentation

June 2000; Vol. 16, No. 6

  • Kids First? How Vaccination Politics Can Undermine Public Health
  • Product Recalls
  • The Health Research Group Launches 'eLetter' Web Site On Prescription Drugs for the Seriously Mentally Ill
  • Dr. Ross (or Nurse Hathaway) Will See You Now
  • Summer: How to Protect Yourself
  • Dangerous Gap in the Drug Safety System
  • Canadian Update on the Drug Celecoxcib (CELEBREX) Confirms HRG Warning
  • Outrage: Mother Dies, But Son Can't Get Explanation Because Her Doctor Won't OK Inquiry's Disclosure

May 2000; Vol. 16, No. 5

  • Ranking of State Medical Board Disciplinary Actions in 1999
  • Do Not Use This Drug: Propulsid Withdrawn from the Market
  • Product Recalls
  • Loyalty in Government Service - to Whom?
  • Reducing Dangers to Pregnant Women
  • Outrage: DRKOOP.CON: America's Family Doctor and his Conflicts of Interest, Part II

April 2000; Vol. 16, No. 4

  • Safety Alert! It Is Better to Curse the Darkness Than to Light This Kind of Candle
  • St. John's Wort: A Growing List of Harmful Drug Interactions
  • Medicare: Few Beneficiaries Use Colorectal Cancer Screening and Diagnostic Services
  • Product Recalls
  • Patients, Doctors Not Warned of Dangers of New Diabetes Drugs
  • Outrage: Health News Feels the Censor's Knife

March 2000; Vol. 16, No. 3

  • Survey of Doctor Disciplinary Information on State Medical Board Web Sites
  • Untested Herbs and Food Supplements for Pregnant Women Making the FDA Retract its Dangerous Regulation
  • Product Recalls
  • New Concerns About Menopausal Hormones and Breast Cancer
  • Outrage: The Unkindest Cut of All: Unnecessary Episiotomies

February 2000; Vol. 16, No. 2

  • Managed Costs, Mismanaged Care
  • Primary Care in the United States - The Best of Times, the Worst of Times
  • Trust Me, I'm a Patient
  • Hollywood Hails a Tobacco Whistle Blower
  • Product Recalls
  • Debate on FDA's Recent Decision on Herbal Products
  • Outrage: Flu Epidemic May Be Just a Flu Advertisement

January 2000; Vol. 16, No. 1

  • Wrong Prescription: Bill Bradley's Health Plan is No Cure
  • For-Profit Kidney Dialysis Centers Compromise Kidney Care
  • Point/Counterpoint: Is it Ethical to Pay Research Subjects Large Sums?
  • Product Recalls
  • Health Letter Volume Index for 1999 and Cumulative Index for 1985-1999
  • Outrage: Study Shows Widespread Medical Errors

Copyright © 2014 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.

 

To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.